Novadigm Therapeutics, Inc.

UEI
CBW9AN2E4WA6
CAGE
47NQ8
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Idcrp staph vaccine study W81XWH16C0125 Medical Command (Army) $3,735,479

Grant awards

Award Agency Obligated Awarded
Development of a staphylococcus aureus ? Candida SP. Vaccine W81XWH1110686 Department of Defense $5,594,000
Development of a staphylococcus aureus-candida SP. Vaccine W81XWH1020035 Department of the Army $3,502,000
Vaccine strategies for candidal infections R42AI071554 National Institutes of Health $1,989,750
Recombinant listeria monocytogenes expressing ALS3: a vaccine against candidiasis R43AI074126 National Institutes of Health $298,561
Development of candida-staphylococcus vaccine W81XWH0810151 Department of the Army $1,691,478

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Novadigm Therapeutics, Inc. registered in SAM.gov?

Novadigm Therapeutics, Inc.'s SAM.gov registration expired on January 17, 2022.

What is Novadigm Therapeutics, Inc.'s most recent federal award?

Novadigm Therapeutics, Inc.'s most recent federal contract award is Idcrp staph vaccine study (W81XWH16C0125), from Medical Command (Army), on September 16, 2016.

On GovTribe

See Novadigm Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login